image
Anixa Biosciences, Inc. ANIX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 3.08
-1.6 %
$ 99.1 M
Market Cap
-7.9
P/E
INCOME STATEMENT
210 K REVENUE
-99.99%
Growth Rates
1Year -99.99%
3Years 0.00%
5Years -28.36%
7Years -4.97%
10Years -5.97%
-11 M OPERATING INCOME
20.64%
Growth Rates
1Year 20.64%
3Years -3.34%
5Years 5.08%
7Years -13.60%
10Years -3.35%
-9.93 M NET INCOME
27.89%
Growth Rates
1Year 27.89%
3Years 0.54%
5Years 6.96%
7Years -10.25%
10Years 0.15%
EFFICIENCY
Earnings Waterfall Anixa Biosciences, Inc.
image
Revenue 210 K
Cost Of Revenue 161 K
Gross Profit 49 K
Operating Expenses 11.1 M
Operating Income -11 M
Other Expenses -1.08 M
Net Income -9.93 M

Income Statement

Millions
Oct-2023 Oct-2022 Oct-2021 Oct-2020 Oct-2019 Oct-2018 Oct-2017 Oct-2016 Oct-2015 Oct-2014 Oct-2013 Oct-2012 Oct-2011 Oct-2010 Oct-2009 Oct-2008 Oct-2007 Oct-2006 Oct-2005 Oct-2004 Oct-2003 Oct-2002 Oct-2001 Oct-2000 Oct-1999 Oct-1998 Oct-1997 Oct-1996 Oct-1995 Oct-1994 Oct-1993 Oct-1992 Oct-1991 Oct-1990 Oct-1989 Oct-1988 Oct-1987 Oct-1986 Oct-1985
REVENUE
Revenue 0.2 2 469.0 0.5 0 0.2 1.1 0.4 0.3 9.3 3.7 0.4 0.9 1.0 0.7 1.1 2.1 0.5 0.5 0.4 0.5 0.2 5.2 1.7 1.5 100 K 100 K 100 K 100 K 100 K 100 K 100 K 100 K 100 K 100 K 100 K 100 K 100 K 100 K 0.3
GROSS PROFIT
Cost Of Revenue 0.2 42 K 0.4 90.2 K 0.2 0.8 0.1 0.2 3.6 2.0 0.3 3.87 K 34.1 K 82.3 K 65.7 K 95.6 K 0.2 0.2 0.7 0.2 0.2 1.9 0.7 0.5 (0.3) (0.3) (0.3) 100 K 100 K 100 K 0 0 0 0 0 0 0 0 0
Gross Profit 49 K 2 469.0 0.1 90.2 K 83.8 K 0.3 0.3 82.6 K 5.6 1.7 72.2 K 0.9 1.0 0.6 1.0 2.0 0.3 0.4 (0.3) 0.3 68.3 K 3.3 1.0 1.0 0.4 0.4 0.4 0.2 0.2 0.2 100 K 100 K 100 K 100 K 100 K 100 K 100 K 100 K 0.3
OPERATING INCOME
Operating Expenses 11.1 13.9 13.3 10.0 11.6 14.1 6.3 4.6 6.6 6.7 8.0 5.1 6.0 5.9 8.3 8.0 5.5 8.0 4.2 3.7 3.2 6.6 4.6 6.1 8.6 7.5 6.7 6.2 3.5 3.8 2.9 2.0 1.5 1.5 1.3 1.4 1.4 1.9 2.0
Selling, General and Administrative Expenses 6.3 7.2 7.1 5.6 5.7 6.9 4.4 2.7 5.5 6.4 8.0 2.9 2.9 2.9 4.2 3.8 2.4 3.4 1.9 1.5 1.4 2.2 4.6 5.8 8.3 7.2 6.4 2.2 1.0 1.0 2.9 2.0 1.5 1.4 1.2 1.3 1.3 1.9 2.0
Research and Development Expenses 4.8 6.7 6.2 4.4 5.5 6.8 1.6 1.6 0.7 1.2 0 2.2 3.1 3.0 4.1 4.1 3.4 4.6 2.3 2.2 1.8 1.6 0 0 0 0 0 3.9 2.4 2.7 0 0 0 0 0 0 0 0 0
Operating Income (11.0) (13.9) (13.1) (10.0) (11.5) (14.3) (6.1) (4.5) (0.9) (5.0) (7.9) (4.1) (5.0) (5.2) (7.3) (6.0) (5.5) (7.6) (4.5) (3.4) (3.1) (3.3) (3.6) (5.1) (8.2) (7.1) (6.3) (6.0) (3.3) (3.6) (2.8) (1.9) (1.4) (1.4) (1.2) (1.3) (1.3) (1.8) (1.7)
PRE-TAX INCOME
Interest Income Expense 0 0.1 322 0 0 0 0.5 0.5 0.5 1.3 1.1 7.66 K 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Other Income 1.1 0.1 7.69 K (0.1) 71.4 K 46 K 1.1 (0.5) (0.4) (4.6) (2.2) (0.1) (1.7) 73.1 K (9.2) 0.2 34.1 K 26.7 K 14.5 K 4.33 K 0 (2.8) 0 0 (0.3) 100 K 0.6 0.6 0.4 0.2 0.2 0.2 0.2 0.3 0.2 100 K 0 1.8 1.7
Pre-Tax Income (9.9) (13.8) (13.1) (10.1) (11.8) (14.2) (5.0) (5.0) (1.4) (9.6) (10.1) (4.3) (6.8) (5.2) (16.5) (5.8) 0 0 0 0 0 (6.1) 0 0 (8.5) (7.0) (5.7) (5.4) (2.9) (3.4) (2.6) (1.7) (1.2) (1.1) (1.0) (1.2) 0 0 0
NET INCOME
Tax Provision 0 (0.3) (0.2) 40.2 K 0.2 0.3 0.5 12.5 K 17.6 K 1.3 1.1 430 0.6 73.1 K 9.2 (0.2) 0.3 26.7 K 14.5 K 4.33 K 4.67 K 23.5 K 32.3 K (0.1) 0.3 0 (0.5) (0.6) (0.3) (0.2) 0.2 100 K 100 K (0.3) 100 K 0 100 K 1.8 1.7
Net Income (9.8) (13.5) (12.9) (10.1) (12.0) (14.0) (5.0) (5.0) (1.4) (9.6) (10.1) (4.3) (7.4) (5.2) (16.5) (5.8) (5.5) (7.6) (4.5) (3.4) (3.1) (3.3) (3.6) (5.0) (8.5) (7.1) (5.8) (5.4) (3.0) (3.4) (2.8) (1.8) (1.3) (1.1) (1.1) (1.3) (1.4) (1.8) (1.7)
EPS 0.32 0.44 0.45 0.46 0.61 0.79 0.41 0.57 0.14 1 1.17 0.53 1.01 0.79 2.7 1.02 1.2 1.81 1.14 0.92 0.94 1.1 1.26 1.81 3.29 2.79 2.29 2.24 1.35 1.59 1.37 0.91 0.68 0.68 0.68 0.68 0.91 1.14 1.14